$19.99 $0.79 per serving
Product analysis
Heart Collagen + Resveratrol combines ingredients with limited support for selected bone, skin and blood-vessel measures. Its generic collagen cannot be assumed equivalent to the specific preparations linked to those benefits.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality54
Vitamin K uses MK-7, a favorable choice of form. The collagen preparation is not explicitly named, and resveratrol’s relative quality remains uncertain.
Ingredient Transparency88
Amounts and the vitamin K and resveratrol forms are stated. The collagen preparation is less fully identified, limiting a complete comparison.
Value For Money30
Value is limited for vitamin K and modest for collagen and resveratrol at the full serving price. Those comparisons make the combination less appealing on value alone.
Customer Satisfaction70
Customer feedback is positive, although the review pool is relatively small. That limits confidence in how broadly the reported satisfaction applies.
Product Focus63
The formula spans bone, skin and selected cardiovascular measures. Those connections are limited and preparation-specific, with no demonstrated additional benefit from the combination.
- Format
Tablet - Container
- 150 Tablet(s)
- Per serving
- $0.79
- Customer rating
- 4.6 · 147 ratings
Goals
Impact
Moderate effect
Vitamin K · 180 mcgCollagen · 2500 mg
Collagen relates to skin structure, while trans-resveratrol has mixed findings for selected cognitive tests and cerebral blood flow in older adults. Vitamin K2 relates to arterial flexibility, but the supplied positive findings concern an identified MenaQ7 preparation rather than all MK-7 products.
These are separate, limited aspects of aging; the generic collagen and unidentified preparations make the evidence less directly applicable.
How this product is rated for Longevity
Ingredient fit91
The saved findings identify 3 relevant ingredients and no other active ingredients. The range of other linked uses also affects the formula's focus. The evaluated amounts fully meet the saved dose benchmarks.
Goal fit
The saved findings identify 3 relevant ingredients and no other active ingredients. The range of other linked uses also affects the formula's focus.
Dose adequacy
The evaluated amounts fully meet the saved dose benchmarks.
Pathways80
The strongest recorded connection is to dermal matrix renewal, with moderate coverage. 3 of the three target processes reaches the saved coverage threshold.
Depth
The strongest recorded connection is to dermal matrix renewal, with moderate coverage.
Breadth
3 of the three target processes reaches the saved coverage threshold.
Evidence30
Collagen provides the strongest recorded evidence contribution, which concerns limited aging-related outcomes rather than lifespan extension. The evaluated ingredients are not recorded as matching the specific research preparations.
Evidence strength
Collagen provides the strongest recorded evidence contribution, which concerns limited aging-related outcomes rather than lifespan extension.
Studied preparation
The evaluated ingredients are not recorded as matching the specific research preparations.
Formulation logic100
The evaluated ingredients can contribute alone or have their relevant partners present. All evaluated ingredients meet the saved minimum dose threshold.
Partner coverage
The evaluated ingredients can contribute alone or have their relevant partners present.
Conflicts
No ingredient conflict was recorded in the supplied findings.
Effective doses
All evaluated ingredients meet the saved minimum dose threshold.
Impact
High effect
Vitamin K · 180 mcgCollagen · 2500 mg
MK-7 supports activation of bone-related proteins, with limited bone-density findings from long-term studies in postmenopausal women. The 180 mcg serving matches one supportive trial's amount, but fracture prevention is unestablished. The hydrolyzed collagen supplies 2.5 g per serving, below the 5 g of specific FORTIBONE peptides used in a bone-density trial; generic collagen cannot be assumed equivalent to that preparation.
How this product is rated for Bone Health
Ingredient fit76
MK-7 provides the clearer bone connection, with a smaller contribution assigned to unidentified collagen material.
Goal fit
MK-7 and collagen are counted for bone health, while another active and multiple linked goals broaden the formula's focus.
Dose adequacy
MK-7 meets its full amount reference; the 2.5 g collagen serving receives partial amount-based credit.
Pathways60
Bone-protein activation is the strongest contribution, with smaller collagen-matrix and remodeling findings.
Depth
MK-7 leads through activation of bone-related proteins.
Breadth
Only bone-protein activation meets the saved coverage criterion; collagen formation and remodeling contributions remain smaller.
Evidence88
Vitamin K as MK-7 leads the saved evidence finding. Nutritional support and bone-density findings do not by themselves establish fracture prevention.
Evidence strength
Vitamin K as MK-7 provides the strongest saved evidence basis here, with the population and nutritional limitations of its supporting findings.
Studied preparation
MK-7 meets the preparation criterion; generic hydrolyzed collagen does not establish equivalence to the studied FORTIBONE peptides.
Formulation logic100
No required partner is missing, and no configured ingredient conflict was found.
Partner coverage
The counted ingredients work alone or have their configured partners.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All counted ingredients meet the saved minimum amount criterion; this is not proof of a clinical bone benefit.
Impact
High effect
Vitamin K · 180 mcg
MK-7 vitamin K has limited support for selected arterial-stiffness measures in postmenopausal women, with the 180 mcg serving matching the daily amount used in the supplied long-term trial. This does not establish prevention of cardiovascular events. Resveratrol findings vary by population and duration, so its presence does not establish a reliable extra cardiovascular benefit.
How this product is rated for Cardiovascular Support
Ingredient fit79
Relevant ingredients sit within a broader formula, so only part of the product is specifically connected to cardiovascular support. The included amounts largely meet the saved references, with some providing only partial exposure compared with those references.
Goal fit
Relevant ingredients sit within a broader formula, so only part of the product is specifically connected to cardiovascular support.
Dose adequacy
The included amounts largely meet the saved references, with some providing only partial exposure compared with those references.
Pathways60
The main recorded connection is arterial calcification control. Coverage is concentrated in a limited set of cardiovascular-related processes, leaving other aspects without substantial support.
Depth
The strongest recorded connection concerns arterial calcification control, with substantial coverage from the included ingredients.
Breadth
Coverage is concentrated in a limited set of cardiovascular-related processes, leaving other aspects without substantial support.
Evidence69
Vitamin K leads the saved evidence findings. Preparation matching does not remove the specific population and outcome limits described above.
Evidence strength
Vitamin K provides the strongest recorded ingredient evidence at a qualifying amount; its population and outcome limitations still apply.
Studied preparation
The saved findings recognize the qualifying preparations as studied; this does not establish that the complete product itself was tested.
Formulation logic100
No listed formulation conflict was matched in the supplied findings. This is limited to the specified checks. The ingredients included in the amount finding meet its minimum threshold.
Partner coverage
The included ingredients do not require an additional missing partner under the supplied findings; this does not establish a combined benefit.
Conflicts
No listed formulation conflict was matched in the supplied findings. This is limited to the specified checks.
Effective doses
All ingredients included in this finding meet its minimum amount threshold; the threshold is not proof of clinical effectiveness.
Impact
High effect
Vitamin K · 180 mcg
Vitamin K as MK-7 has limited support for arterial-stiffness measures in studied postmenopausal populations, without established general cardiovascular-event prevention. Resveratrol has mixed and limited findings on selected vascular measures. Its amount does not establish a stable preventive effect, and the supplied evidence does not demonstrate extra benefit from combining it with MK-7.
How this product is rated for Heart Health
Ingredient fit79
Vitamin K, Resveratrol provide the included contribution, with partial coverage of the comparison amounts.
Goal fit
Vitamin K, Resveratrol contribute alongside ingredients directed at other uses.
Dose adequacy
The included amounts partly cover the saved comparison ranges, which describe exposure rather than proven treatment doses.
Pathways60
The strongest recorded connection is arterial calcification control, with full coverage of the comparison range.
Depth
The strongest recorded connection is arterial calcification control, with full coverage of the comparison range.
Breadth
Arterial calcification control reached the coverage threshold; the remaining configured pathways did not.
Evidence77
Vitamin K provides the strongest included evidence, within the limits of its studied outcomes and populations.
Evidence strength
Vitamin K provides the strongest included evidence, within the limits of its studied outcomes and populations.
Studied preparation
The included preparations were matched to studied material, within the limits of the outcomes and populations studied.
Formulation logic100
No configured ingredient conflict was identified. The included ingredients can stand alone or have their required partner present.
Partner coverage
The included ingredients can stand alone or have their required partner present.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All included ingredients clear the saved minimum amount threshold; this does not guarantee a noticeable clinical benefit.
Impact
Moderate effect
Collagen · 2500 mg
Resveratrol at 200 mg relates to limited, inconsistent inflammatory-marker findings. Hydrolyzed collagen can support connective tissue, but that role is separate from reducing systemic inflammation, and the vitamin K form has no established matching anti-inflammatory benefit in the supplied evidence.
How this product is rated for Inflammation
Ingredient fit59
The saved findings identify 2 relevant ingredients and 1 other active ingredients (Vitamin K). The saved amount assessment is limited relative to the comparison amounts; undisclosed amounts cannot strengthen it.
Goal fit
The saved findings identify 2 relevant ingredients and 1 other active ingredients (Vitamin K).
Dose adequacy
The saved amount assessment is limited relative to the comparison amounts; undisclosed amounts cannot strengthen it.
Pathways12
The strongest identified area is Inflammatory gene signalling (NF-kB). 0 of 3 areas reach the saved coverage threshold.
Depth
The strongest identified area is Inflammatory gene signalling (NF-kB).
Breadth
0 of 3 areas reach the saved coverage threshold.
Evidence72
Collagen provides the strongest evidence contribution among ingredients at the saved comparison amount. Only part of the assessed preparations match studied preparations at effective comparison amounts.
Evidence strength
Collagen provides the strongest evidence contribution among ingredients at the saved comparison amount.
Studied preparation
Only part of the assessed preparations match studied preparations at effective comparison amounts.
Formulation logic100
The assessed ingredients can work alone or have their identified partner present. No matched ingredient conflicts were recorded in the saved findings. 2 of 2 assessed ingredients reach the saved minimum comparison amount.
Partner coverage
The assessed ingredients can work alone or have their identified partner present.
Conflicts
No matched ingredient conflicts were recorded in the saved findings.
Effective doses
2 of 2 assessed ingredients reach the saved minimum comparison amount.
Impact
High effect
Collagen · 2500 mgResveratrol · 200 mg
Hydrolyzed collagen has limited support for selected skin-structure and hydration outcomes, but this generic material does not establish the peptide preparation used in trials. Higher-quality collagen analyses weaken confidence in the overall findings. Resveratrol skin findings come from a multi-ingredient blend and cannot establish benefit from isolated resveratrol here.
How this product is rated for Skin Health
Ingredient fit79
Collagen, Resveratrol provide the recognized skin connections. Amount or preparation limitations reduce the combined finding.
Goal fit
Relevant ingredients sit within a broader formula with several actives not established for this goal.
Dose adequacy
Some recognized amounts receive partial recognition; the combined amount finding is below the supplied reference level.
Pathways70
The strongest recognized coverage concerns uv antioxidant defence. Skin structure and UV-related contributions both meet the supplied coverage requirement.
Depth
UV antioxidant defence is the strongest recognized area; the supplied ingredient limitations still constrain practical expectations.
Breadth
Skin structure and UV antioxidant defence meet the supplied coverage requirement; hydration and barrier coverage remain limited.
Evidence72
Resveratrol leads the saved evidence finding. Preparation, population and outcome limitations constrain transfer to routine skin benefits.
Evidence strength
Resveratrol has the strongest recognized evidence among the counted ingredients; its specific limitations determine which skin benefits can be described.
Studied preparation
The collagen identity does not establish the tested peptide preparation; resveratrol retains preparation recognition without proving isolated-ingredient skin benefit.
Formulation logic100
No required partner is missing and no assessed conflict is recorded among the counted ingredients.
Partner coverage
The counted ingredients do not require an additional missing partner; no extra combination benefit is established.
Conflicts
No assessed conflict is recorded; this does not establish comprehensive interaction testing.
Effective doses
All counted ingredients meet the saved minimum amount criterion, which is not proof of a clinically effective cosmetic dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin K2 (Menaquinone-7) | 180 mcg | |
hydrolyzed Collagen | 2500 mg | |
Resveratrol (Pure Trans-Resveratrol) | 200 mg |
Vitamin K (Menaquinone-7) · 180 mcg OverallScore77
A serving lists 180 mcg of vitamin K2 as MK-7. A whole-product serving costs about $0.80.
How this ingredient is rated
Active Ingredient Quality & Bioavailability82
The vitamin K2 is identified as MK-7; its trans designation is not established.
Vitamin K Form (MK-7 vs. MK-4 vs. K1)
The identified form is vitamin K2 as MK-7.
MK-7 Isomer Disclosure
MK-7 is identified, but a trans designation is not established in the saved facts.
Dose, Safety & Label Transparency100
The serving individually lists 180 mcg of MK-7.
Vitamin K2 (MK-7) Dosage Efficacy
The serving lists 180 mcg of MK-7.
Form and Subtype Transparency
The amount and subtype are identified as 180 mcg of MK-7 per serving.
Value20
A whole-product serving costs about $0.80; the price covers the whole product, not vitamin K alone.
Price per Effective MK-7 Serving
A whole-product serving costs about $0.80; the price covers the whole product, not vitamin K alone.
Resveratrol (Pure Trans-Resveratrol) · 200 mg OverallScore79
Each serving lists 200 mg of trans-resveratrol. Based on the whole-product serving price, that corresponds to about $1.00 per 250 mg of trans-resveratrol.
How this ingredient is rated
Composition and Label Disclosure77
Trans-resveratrol is named and its amount is stated, but a trans-resveratrol concentration is not established in the saved facts.
Explicit Label Detail
The trans form of resveratrol is identified.
Trans-Resveratrol Concentration Disclosure
The saved facts do not establish a numerical trans-resveratrol concentration for the preparation.
Composition and Label Disclosure100
The serving lists 200 mg of trans-resveratrol, so the trans-specific amount is known.
Resveratrol Amount Disclosure
The serving lists 200 mg of trans-resveratrol, so the trans-specific amount is known.
Commercial Price and Usability40
The whole-product serving costs about $0.80, equivalent to about $1.00 per 250 mg of trans-resveratrol.
Cost per 250 mg Declared Trans-Resveratrol
The whole-product serving costs about $0.80, equivalent to about $1.00 per 250 mg of trans-resveratrol.
Collagen · 2500 mg OverallScore49
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effect of Calcium and Vitamin D Supplementation With and Without Collagen Peptides on Volumetric and Areal Bone Mineral Density, Bone Geometry and Bone Turnover in Postmenopausal Women With Osteopenia.
- Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies.
- A calcium-collagen chelate dietary supplement attenuates bone loss in postmenopausal women with osteopenia: a randomized controlled trial.
- Assessment of Osteoporosis in Lumbar Spine: In Vivo Quantitative MR Imaging of Collagen Bound Water in Trabecular Bone.
- Effect of calcium and vitamin D supplementation with and without collagen peptides on bone turnover in postmenopausal women with osteopenia.
- Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
- Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
- Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
- Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
- Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.
- Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.
- Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases.
- Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults.
- Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial.
- Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
- Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
- Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
- Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
- Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.